St. Jude Medical expects to acquire rest of CardioMEMS in Q2 St. Jude Medical and CardioMEMS confirmed FDA approval of the CardioMEMS HF System. The CardioMEMS HF System is the first and only FDA-approved heart failure monitoring device that has been proven to significantly reduce HF hospital admissions when used by physicians to manage heart failure. In September 2010, St. Jude Medical invested $60M for 19% ownership of CardioMEMS, with an exclusive option to purchase the remaining 81% of the company for $375M. St. Jude Medical now intends to immediately exercise its exclusive option to acquire CardioMEMS, and expects to complete the acquisition in Q2.
News For STJ From The Last 14 Days
Check below for free stories on STJ the last two weeks.